Epigenetic reader domain inhibitor (+)-JQ1 PA, Purity ≥98%

Cat. No.: X24-05-ZQ406

Epigenetic reader domain inhibitor (+)-JQ1 PA, Purity ≥98%

Synonym: 2115701-93-2; (+)-JQ1 PA; (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(prop-2-yn-1-yl)acetamide; Epigenetic reader domain inhibitor

  • CAS Number: 2115701-93-2
  • Compound CID: 134821687
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
(+)-JQ1 PA disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.
Molecular Weight
437.95
Molecular Formula
C22H20ClN5OS
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
(+)-JQ1 PA is used to investigate the selective inhibition of BET bromodomains, aiding in the study of gene expression regulation and potential therapeutic applications.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.